Skip to content

BVI Medical Achieves FDA 510(k) Clearance for Leos

๐๐•๐ˆ ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐€๐œ๐ก๐ข๐ž๐ฏ๐ž๐ฌ ๐…๐ƒ๐€ 510(๐ค) ๐‚๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž ๐Ÿ๐จ๐ซ ๐‹๐ž๐จ๐ฌโ„ข

๐Ÿค BVI Medical have shared that they have received FDA 510(k) clearance for Leosโ„ข (Laser Endoscopy Ophthalmic System) โ€“ a groundbreaking innovation set to redefine glaucoma surgery.

๐Ÿ‘ Leosโ„ข delivers a novel and intuitive approach to Laser ECP (Endoscopic Cyclophotocoagulation), enhancing precision and seamlessly integrating into the surgical workflow. This milestone marks a significant step forward in our commitment to transforming ophthalmic care and improving outcomes for patients living with glaucoma.

GlaucomaSurgery FDAApproval OphthalmologyInnovation